After finishing at $9.92 in the prior trading day, Ventyx Biosciences Inc (NASDAQ: VTYX) closed at $8.04, down -18.95%. In other words, the price has decreased by -$1.88 from its previous closing price. On the day, 7710666 shares were traded. VTYX stock price reached its highest trading level at $10.67 during the session, while it also had its lowest trading level at $6.82.
Ratios:
Our goal is to gain a better understanding of VTYX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.87 and its Current Ratio is at 11.87. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on November 07, 2023, Downgraded its rating to Equal Weight and sets its target price to $8 from $77 previously.
On November 07, 2023, Stifel Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 20 ’23 when Mohan Raju sold 58,860 shares for $2.12 per share. The transaction valued at 124,660 led to the insider holds 1,570,719 shares of the business.
Nuss John sold 17,628 shares of VTYX for $37,334 on Dec 20 ’23. The Chief Scientific Officer now owns 262,118 shares after completing the transaction at $2.12 per share. On Dec 20 ’23, another insider, Krueger Christopher W, who serves as the Chief Business Officer of the company, sold 5,293 shares for $2.12 each. As a result, the insider received 11,210 and left with 282,119 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 587.65M and an Enterprise Value of 347.94M.
Stock Price History:
The Beta on a monthly basis for VTYX is 0.36, which has changed by -74.03% over the last 52 weeks, in comparison to a change of 30.58% over the same period for the S&P500. Over the past 52 weeks, VTYX has reached a high of $44.72, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 3.70, while the 200-Day Moving Average is calculated to be 19.31.
Shares Statistics:
The stock has traded on average 4.53M shares per day over the past 3-months and 5.24M shares per day over the last 10 days, according to various share statistics. A total of 59.24M shares are outstanding, with a floating share count of 47.09M. Insiders hold about 20.51% of the company’s shares, while institutions hold 77.03% stake in the company. Shares short for VTYX as of Feb 15, 2024 were 5.59M with a Short Ratio of 1.23, compared to 4.98M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.43% and a Short% of Float of 14.17%.
Earnings Estimates
Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.74 for the current quarter, with a high estimate of -$0.52 and a low estimate of -$0.86, while EPS last year was -$0.68. The consensus estimate for the next quarter is -$0.7, with high estimates of -$0.5 and low estimates of -$0.87.
Analysts are recommending an EPS of between -$1.67 and -$4.18 for the fiscal current year, implying an average EPS of -$2.9. EPS for the following year is -$3.19, with 8 analysts recommending between -$1.25 and -$5.21.
